2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases
Methodological detailssystematic literature review, GRADE methodology, Voting Panel consensus
- Systematic literature review
- GRADE methodology
- Voting Panel consensus
Recommendations
As issued by the authors
- conditional
Screening of people with these systemic autoimmune rheumatic diseases (SARDs) at risk for interstitial lung disease (ILD): Pulmonary function tests (PFTs) and HRCT chest
- conditional against
Screening with 6MWD, chest radiography, ambulatory desaturation testing, or bronchoscopy
- strong against
Screening with surgical lung biopsy
- conditional
Monitoring ILD with PFTs, HRCT chest, and ambulatory desaturation testing
- conditional against
Monitoring with 6MWD, chest radiography, or bronchoscopy
Original publication
2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases. Arthritis Care Res (Hoboken). Published 8 July 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →